203 related articles for article (PubMed ID: 16150246)
41. Followup of patients with papillary thyroid cancer: in search of the optimal algorithm.
Mittendorf EA; Wang X; Perrier ND; Francis AM; Edeiken BS; Shapiro SE; Lee JE; Evans DB
J Am Coll Surg; 2007 Aug; 205(2):239-47. PubMed ID: 17660070
[TBL] [Abstract][Full Text] [Related]
42. Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/ml determined by traditional assays?
Rosario PW; Purisch S
Clin Endocrinol (Oxf); 2008 Mar; 68(3):338-42. PubMed ID: 17850379
[TBL] [Abstract][Full Text] [Related]
43. Thyroglobulin and thyroid cancer.
Lo Gerfo P; Birnbaum S; Li Volsi V; Scholes J
Surg Forum; 1977; 28():133-5. PubMed ID: 617395
[No Abstract] [Full Text] [Related]
44. Postoperative radioactive iodine administration for differentiated thyroid cancer patients.
Lepoutre-Lussey C; Deandreis D; Leboulleux S; Schlumberger M
Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):363-71. PubMed ID: 25119656
[TBL] [Abstract][Full Text] [Related]
45. Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients.
Schlumberger M; Lacroix L; Russo D; Filetti S; Bidart JM
Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):260-9. PubMed ID: 17315034
[TBL] [Abstract][Full Text] [Related]
46. Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management.
Giovanella L
Clin Chem Lab Med; 2008; 46(8):1067-73. PubMed ID: 18605946
[TBL] [Abstract][Full Text] [Related]
47. [Current practice in treatment of differentiated thyroid cancer in Japan in comparison with the guidelines in Western countries].
Miyauchi A
Nihon Rinsho; 2007 Nov; 65(11):2023-8. PubMed ID: 18018565
[TBL] [Abstract][Full Text] [Related]
48. [Treatment of well-differentiated thyroid cancer].
Roisman I; Lifshitz I; Sapir D; Bitterman A; Toledano H; Durst AL
Harefuah; 1995 Mar; 128(6):340-8, 400. PubMed ID: 7750812
[TBL] [Abstract][Full Text] [Related]
49. Differentiated thyroid carcinoma: defining new paradigms for postoperative management.
Durante C; Costante G; Filetti S
Endocr Relat Cancer; 2013 Aug; 20(4):R141-54. PubMed ID: 23572163
[TBL] [Abstract][Full Text] [Related]
50. Thyroglobulin-positive, radioiodine-negative thyroid cancer.
Levy EG
Thyroid; 2001 Jun; 11(6):599-602. PubMed ID: 11442009
[No Abstract] [Full Text] [Related]
51. Use of recombinant thyrotropin.
Toft A; Beckett G
Lancet; 2002 Jun; 359(9321):1874-5. PubMed ID: 12057547
[No Abstract] [Full Text] [Related]
52. Management of thyroid cancer.
Blahd WH
Compr Ther; 1993; 19(5):197-202. PubMed ID: 8275665
[No Abstract] [Full Text] [Related]
53. Imaging surveillance of differentiated thyroid cancer.
Johnson NA; LeBeau SO; Tublin ME
Radiol Clin North Am; 2011 May; 49(3):473-87, vi. PubMed ID: 21569906
[TBL] [Abstract][Full Text] [Related]
54. A highly sensitive thyroglobulin assay has superior diagnostic sensitivity for recurrence of differentiated thyroid cancer in patients undergoing TSH suppression.
Zöphel K; Wunderlich G; Kotzerke J
J Nucl Med; 2006 Mar; 47(3):552-3; author reply 553. PubMed ID: 16513626
[No Abstract] [Full Text] [Related]
55. Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients.
Castagna MG; Cantara S; Pacini F
J Endocrinol Invest; 2016 Oct; 39(10):1087-94. PubMed ID: 27350556
[TBL] [Abstract][Full Text] [Related]
56. [The treatment of differentiated thyroid cancer].
Hubold C; Buchmann I; Lehnert H
Dtsch Med Wochenschr; 2011 Apr; 136(17):891-5. PubMed ID: 21523640
[No Abstract] [Full Text] [Related]
57. Long-term management of differentiated thyroid cancer.
Ross DS
Endocrinol Metab Clin North Am; 1990 Sep; 19(3):719-39. PubMed ID: 2261913
[TBL] [Abstract][Full Text] [Related]
58. [Treatment and follow-up of thyroid cancer].
Välimäki M
Duodecim; 1991; 107(6):456-60. PubMed ID: 1364893
[No Abstract] [Full Text] [Related]
59. Usefulness of serum thyroglobulin at replacement withdrawal after thyroidectomy for differentiated thyroid cancer.
Panza N; De Rosa M; Lombardi G; Salvatore M
J Nucl Med; 1985 Mar; 26(3):316-7. PubMed ID: 3973744
[No Abstract] [Full Text] [Related]
60. Detection of disease recurrence in differentiated thyroid cancer.
Shin JJ; Milas M
Minerva Chir; 2010 Feb; 65(1):101-16. PubMed ID: 20212422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
